MARKET

PMD

PMD

Psychemedics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.99
-0.04
-0.57%
Opening 09:32 04/14 EDT
OPEN
6.99
PREV CLOSE
7.03
HIGH
6.99
LOW
6.99
VOLUME
164
TURNOVER
--
52 WEEK HIGH
7.90
52 WEEK LOW
3.580
MARKET CAP
38.70M
P/E (TTM)
-10.0072
1D
5D
1M
3M
1Y
5Y
Global Analytical Instruments for Drug Screening Sales Market Size 2021 Analysis By Current Industry Status, Growth Opportunities, Industry Trends Under COVID-19, Top Key Players, Target Audience and Forecast To 2027
The Express Wire · 6h ago
Drug Screening Market Report – Global Outlook and Forecast 2020-2027
Apr 12, 2021 (Market Insight Reports) -- The global drug screening market is estimated to reach value of USD 13.56 Billion by 2027, according to a current...
Market Insight Reports · 2d ago
Drug of Abuse Testing Market 2021 Size, Growth, Share, Global Industry Current Trends, Analysis of Top Companies, Demand, Application, Development and Forecast to 2025 Research Report
Apr 12, 2021 (The Expresswire) -- Global “ Drug of Abuse Testing Market” global industry studies provides a comprehensive view of market growth, trends,...
The Express Wire · 2d ago
Drug Screening Market Industry Analysis, Market Size, Trends, Share and Forecast 2027
Apr 09, 2021 (Market Insight Reports) -- Global Drug Screening Market is poised to value over USD 11.5 billion by 2027 end at a CAGR of over 9.2% during the...
Market Insight Reports · 5d ago
At-Home Drug of Abuse (DOA) Testing Market Size Analysis by Competitive Landscape 2021 Latest Research by Top Key Players, Global Share with SWOT Analysis, and Growth Analysis with Revenue till 2027
The Express Wire · 5d ago
Drug Screening Industry 2021 Size, Growth, Global Market Trends, Share, Competitive Analysis, Statistics, Regional, Demand, Development Status, Opportunities Forecast to 2025
Apr 06, 2021 (The Expresswire) -- Global “Drug Screening Market” is a comprehensive research that provides information regarding Drug Screening market size,...
The Express Wire · 04/06 09:01
10-K: PSYCHEMEDICS CORP
(EDGAR Online via COMTEX) -- Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations The Management's Discussion and...
Edgar Online - (EDG = 10Q, 10K) · 03/26 21:02
Global Drug of Abuse Testing Market Report 2021-2026 With Top Countries Data Industry Insights by Share, Emerging Trends, Regional Analysis, Segments, Prime Players, Drivers, Growth Factor and Foreseen | With Covid 19 Analysis
Mar 25, 2021 (The Expresswire) -- “Drug of Abuse Testing Market” Report (2021-2026) offers a learned and top to bottom investigation on the current situation...
The Express Wire · 03/25 04:14
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PMD. Analyze the recent business situations of Psychemedics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
Institutional Holdings
Institutions: 54
Institutional Holdings: 2.47M
% Owned: 44.56%
Shares Outstanding: 5.54M
TypeInstitutionsShares
Increased
3
36.51K
New
3
41.00K
Decreased
15
122.71K
Sold Out
5
190.63K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+1.03%
Healthcare Providers & Services
+0.79%
Key Executives
Chairman/Director/President/Chief Executive Officer
Raymond Kubacki
Executive Vice President
Charles Doucot
Vice President - Operations
Michael Schaffer
Vice President/Controller
Andrew Limbek
Independent Director
Harry Connick
Independent Director
Robyn Davis
Independent Director
Walter Tomenson
Independent Director
Fred Weinert
Declaration Date
Dividend Per Share
Ex-Div Date
02/11/2020
Dividend USD 0.18
02/20/2020
10/22/2019
Dividend USD 0.18
11/04/2019
07/23/2019
Dividend USD 0.18
08/05/2019
04/23/2019
Dividend USD 0.18
05/06/2019
03/04/2019
Dividend USD 0.18
03/13/2019
10/23/2018
Dividend USD 0.18
11/01/2018
07/24/2018
Dividend USD 0.18
08/06/2018
04/24/2018
Dividend USD 0.18
05/07/2018
03/07/2018
Dividend USD 0.15
03/16/2018
10/24/2017
Dividend USD 0.15
11/03/2017
08/02/2017
Dividend USD 0.15
08/10/2017
04/25/2017
Dividend USD 0.15
05/04/2017
02/06/2017
Dividend USD 0.15
02/14/2017
10/26/2016
Dividend USD 0.15
11/03/2016
07/26/2016
Dividend USD 0.15
08/03/2016
04/26/2016
Dividend USD 0.15
05/04/2016
02/10/2016
Dividend USD 0.15
02/18/2016
10/28/2015
Dividend USD 0.15
11/05/2015
07/28/2015
Dividend USD 0.15
08/05/2015
04/27/2015
Dividend USD 0.15
05/06/2015
02/10/2015
Dividend USD 0.15
02/19/2015
10/30/2014
Dividend USD 0.15
11/06/2014
07/28/2014
Dividend USD 0.15
08/05/2014
04/29/2014
Dividend USD 0.15
05/07/2014
02/10/2014
Dividend USD 0.15
02/19/2014
10/28/2013
Dividend USD 0.15
11/06/2013
08/05/2013
Dividend USD 0.15
08/13/2013
05/07/2013
Dividend USD 0.15
05/15/2013
02/25/2013
Dividend USD 0.15
03/05/2013
11/05/2012
Dividend USD 0.15
11/13/2012
08/07/2012
Dividend USD 0.15
08/15/2012
05/08/2012
Dividend USD 0.15
05/16/2012
02/23/2012
Dividend USD 0.15
03/01/2012
11/03/2011
Dividend USD 0.12
11/15/2011
08/10/2011
Dividend USD 0.12
08/18/2011
05/05/2011
Dividend USD 0.12
05/12/2011
--
Dividend USD 0.12
03/09/2011
--
Dividend USD 0.12
11/23/2010
--
Dividend USD 0.12
09/01/2010
05/11/2010
Dividend USD 0.12
06/03/2010
02/23/2010
Dividend USD 0.12
03/03/2010
11/04/2009
Dividend USD 0.12
12/01/2009
--
Dividend USD 0.12
09/02/2009
--
Dividend USD 0.17
06/03/2009
--
Dividend USD 0.17
03/04/2009
--
Dividend USD 0.17
12/02/2008
--
Dividend USD 0.17
09/03/2008
--
Dividend USD 0.17
06/04/2008
--
Dividend USD 0.15
03/05/2008
--
Dividend USD 0.15
11/29/2007
More
About PMD
Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company's drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The Company's primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company's tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time.

Webull offers kinds of Psychemedics Corp. stock information, including NASDAQ:PMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PMD stock methods without spending real money on the virtual paper trading platform.